Half-year Report

AI SummaryClose X

OptiBiotix Health PLC reported a strong period of growth in its half year report. Revenue increased by 102% to £557k, up from £276k in H1 2024. The gross profit margin also improved to 54%, compared to 40% in the previous year, resulting in a gross profit increase of 173% to £303k from £111k. Administrative costs remained relatively stable at £1.15m. The company maintains a strong cash balance of £1.3m. The total value of investments at 30 June 2025 was £6.016m. The loss for the period was £1.177m, with a basic loss per share of (1.15) pence.

Disclaimer*

UK 100

Latest directors dealings